Patients and methods Samples of knee synovial fluid were obtained from patients with RA and OA. All patients with RA fulfilled the American Rheumatism Association criteria for classical or defmite RA and were receiving a variety of non-steroidal anti-inflammatory agents and slow acting antirheumatic drugs. All patients with OA showed clear radiographic and clinical evidence of the disease. The synovial fluids were collected in sodium citrate (3% w/v), centrifuged, treated with hyaluronidase, and stored at -70°C until use. Normal human serum was obtained from healthy volunteers.
Slices of normal human articular cartilage were taken from the femoral heads of patients who were undergoing hemiarthroplasty following osteoporotic subcapital fracture of the femoral neck and also from samples obtained from the upper tibia of two patients following severe tibial plateau fracture. In the last two cases small samples of cartilage, which could not be reconstructed into the joint surface owing to fracture comminution, were removed at the time of operative fixation. Slices of arthritic cartilage were obtained from patients with RA and OA undergoing total hip or knee replacement. Ten 3x3 mm biopsy specimens were taken at random from cartilage slices of each joint and used to determine the intrinsic glycosaminoglycan content of the cartilage.
For culture experiments biopsy specimens were cut in half and the two pieces were placed in separate wells of a 24 well plate. One of the pieces (control biopsy specimen) was cultured in 2 ml of medium (RPMI 1640 supplemented with glutamine, penicillin streptomycin, HEPES (N-2-hydroxyethylpiperazine-N' -2-ethanesulphonic acid) and 5% heat inactivated normal human AB serum). The The glycosaminoglycan content of cartilage biopsy specimens was measured after incubation for two days with or without synovial fluid or normal human serum. Rheumatoid arthritis and OA synovial fluids induced up to 38% loss of glycosaminoglycans from normal cartilage (mean (SD) for RA synovial fluid 17-6 (11-2) ,tg/mg; n=27 and for OA synovial fluid 19-8 (10-9) ,ug/mg; n=5), whereas normal human serum induced no more than 14% glycosaminoglycan loss (mean (SD) 4-8±(7-1) tig/mg; n=5).
These differences were significant (p<0-01 for RA synovial fluid v normal human serum and p<005 for OA synovial fluid v normal human serum). In subsequent experiments RA synovial fluids were found to induce a similar glycosaminoglycan loss from RA cartilage. To determine whether synovial fluid degrades cartilage directly or by stimulating chondrocytes, 15 RA synovial fluids were tested for their ability to degrade normal cartilage which had been killed by repeated freeze thawing. As shown in the figure the RA synovial fluids degraded dead cartilage significantly less well than they degraded living cartilage (p<0-01). However, 10 ng/ml of recombinant human ILla, IL (12) for ILla, -2 (12) for IL11I, 3 (7) for tumour necrosis factor a, and -4 (1) for the mixture of all three cytokines. Higher and lower concentrations of the cytokines were equally ineffective (data not shown). The recombinant human ILla and IL1IB were both effective in stimulating proliferation of mouse thymocytes and their activity was inhibited by specific neutralising antisera (data not shown).
Discussion
Depletion of cartilage matrix, both close to and distant from the cartilage/synovium junction, is a common feature of RA,8 and we have found that cartilage from patients with severe arthritis has a significantly lower glycosaminoglycan concentration than normal cartilage. The results with synovial fluid reported here support the hypothesis that these differences are due to degradation of cartilage matrix by components of synovial fluid, as both RA and OA synovial fluids induced glycosaminoglycan loss from living human cartilage in vitro. Killed cartilage was not affected by RA synovial fluid, indicating that the degradation is chondrocyte dependent and probably, therefore, endogenous ILl and tumour necrosis factor in the synovial fluid play a part. 1 2 Surprisingly, recombinant cytokines, either on their own or in combination with each other, and at concentrations similar to those in RA synovial fluid,9 10 were unable to degrade normal human cartilage in this system. These results contrast strikingly with previous studies using animal cartilage '-5 
